Walter A. Tatarowicz

496 total citations
10 papers, 379 citations indexed

About

Walter A. Tatarowicz is a scholar working on Epidemiology, Infectious Diseases and Pharmacology. According to data from OpenAlex, Walter A. Tatarowicz has authored 10 papers receiving a total of 379 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Epidemiology, 2 papers in Infectious Diseases and 2 papers in Pharmacology. Recurrent topics in Walter A. Tatarowicz's work include Herpesvirus Infections and Treatments (4 papers), Cytomegalovirus and herpesvirus research (4 papers) and Clostridium difficile and Clostridium perfringens research (2 papers). Walter A. Tatarowicz is often cited by papers focused on Herpesvirus Infections and Treatments (4 papers), Cytomegalovirus and herpesvirus research (4 papers) and Clostridium difficile and Clostridium perfringens research (2 papers). Walter A. Tatarowicz collaborates with scholars based in United States. Walter A. Tatarowicz's co-authors include Stephen Villano, Kim D. Thompson, Nell S. Lurain, Lynne Strasfeld, Dale N. Gerding, Michael Seiberling, Antonio Arrieta, Robin K. Avery, Szu‐Yi Chou and Francisco M. Marty and has published in prestigious journals such as The Journal of Infectious Diseases, Antimicrobial Agents and Chemotherapy and The American Journal of Surgery.

In The Last Decade

Walter A. Tatarowicz

10 papers receiving 360 citations

Peers

Walter A. Tatarowicz
Irma Hoyo Spain
Gregory A. Storch United States
J. Portnoy Canada
M. G. Smith Australia
J. Carquin France
David M. Simon United States
Walter A. Tatarowicz
Citations per year, relative to Walter A. Tatarowicz Walter A. Tatarowicz (= 1×) peers Nadia Litvinov

Countries citing papers authored by Walter A. Tatarowicz

Since Specialization
Citations

This map shows the geographic impact of Walter A. Tatarowicz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Walter A. Tatarowicz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Walter A. Tatarowicz more than expected).

Fields of papers citing papers by Walter A. Tatarowicz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Walter A. Tatarowicz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Walter A. Tatarowicz. The network helps show where Walter A. Tatarowicz may publish in the future.

Co-authorship network of co-authors of Walter A. Tatarowicz

This figure shows the co-authorship network connecting the top 25 collaborators of Walter A. Tatarowicz. A scholar is included among the top collaborators of Walter A. Tatarowicz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Walter A. Tatarowicz. Walter A. Tatarowicz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Villano, Stephen, et al.. (2012). Evaluation of an Oral Suspension of VP20621, Spores of Nontoxigenic Clostridium difficile Strain M3, in Healthy Subjects. Antimicrobial Agents and Chemotherapy. 56(10). 5224–5229. 82 indexed citations
2.
Avery, Robin K., Francisco M. Marty, Lynne Strasfeld, et al.. (2010). Oral maribavir for treatment of refractory or resistant cytomegalovirus infections in transplant recipients. Transplant Infectious Disease. 12(6). 489–496. 93 indexed citations
3.
Strasfeld, Lynne, Ingi Lee, Walter A. Tatarowicz, Stephen Villano, & Sunwen Chou. (2010). Virologic Characterization of Multidrug‐Resistant Cytomegalovirus Infection in 2 Transplant Recipients Treated with Maribavir. The Journal of Infectious Diseases. 202(1). 104–108. 46 indexed citations
4.
Tatarowicz, Walter A., Andrew Pekosz, Stephen F. Madden, et al.. (1997). Repression of the HSV-1 latency-associated transcript (LAT) promoter by the early growth response (EGR) proteins: Involvement of a binding site immediately downstream of the TATA box. Journal of NeuroVirology. 3(3). 212–224. 21 indexed citations
5.
Tatarowicz, Walter A., Nell S. Lurain, & Kim D. Thompson. (1992). A Ganciclovir-Resistant Clinical Isolate of Human Cytomegalovirus Exhibiting Cross-Resistance to Other DNA Polymerase Inhibitors. The Journal of Infectious Diseases. 166(4). 904–907. 71 indexed citations
6.
Tatarowicz, Walter A., Nell S. Lurain, & Kim D. Thompson. (1991). In situ ELISA for the evaluation of antiviral compounds effective against human cytomegalovirus. Journal of Virological Methods. 35(2). 207–215. 29 indexed citations
7.
Dobrin, Philip B., et al.. (1991). Efficacy of intraperitoneal antibiotics in the treatment of severe fecal peritonitis. The American Journal of Surgery. 162(5). 453–456. 13 indexed citations
8.
Dobrin, Philip B., et al.. (1989). The value of continuous 72-hour peritoneal lavage for peritonitis. The American Journal of Surgery. 157(4). 368–371. 4 indexed citations
9.
Venezio, Frank R., Walter A. Tatarowicz, C. A. DiVincenzo, & J. Paul O'Keefe. (1986). Activity of ciprofloxacin against multiply resistant strains of Pseudomonas aeruginosa, Staphylococcus epidermidis, and group JK corynebacteria. Antimicrobial Agents and Chemotherapy. 30(6). 940–941. 17 indexed citations
10.
Thompson, Kim D., J. Paul O'Keefe, & Walter A. Tatarowicz. (1984). In vitro comparison of amifloxacin and six other antibiotics against aminoglycoside-resistant Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy. 26(2). 275–276. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026